Market Overview:
The global automatic blood group diagnostic instrument market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for blood transfusions and rising prevalence of blood-borne diseases. Additionally, technological advancements in the field of automatic blood group diagnostics are also propelling the growth of this market. Based on type, the global automatic blood group diagnostic instrument market is segmented into nucleic acid amplification techniques, microbiological technique, and immunohematology techniques. The nucleic acid amplification techniques segment is expected to grow at a CAGR of 7% during the forecast period from 2018 to 2030. This high growth rate can be attributed to technological advancements in this field that have led to improved accuracy and speed in diagnosis. Based on application, the global automatic blood group diagnostic instrument market is segmented into blood typing, antibody screening, and others (including research applications). The antibody screening segment is expected to grow at a CAGR of 7% during the forecast period from 2018to 2030 owingto rising demand for accurate diagnosisof autoimmune diseasesand infections caused by pathogens such as HIV and hepatitis B &C viruses .
Product Definition:
An automatic blood group diagnostic instrument is a device used to determine the blood group of a patient. This is an important tool in diagnosing and treating patients, as knowing a patient's blood group can help doctors choose the best course of treatment.
Nucleic Acid Amplification Techniques:
Nucleic acid amplification is a process by which the genetic material of an organism, DNA in the case of humans, is used to copy itself millions of times. This process is known as polymerase activity and it allows medical practitioners to detect blood group antigens on surfaces of red blood cells and also on skin or tissue samples.
Microbiological Technique:
Microbiological technique and it's usage in the global automatic blood group diagnostic instrument market is expected to grow at a significant pace during the forecast period. The major factor that propels this growth includes rising incidences of infectious diseases coupled with increasing demand for rapid, accurate, and sensitive testing techniques.
Application Insights:
The others segment includes the diagnosis of blood group anomalies and compatibility testing. The Others segment held the largest share in 2017 due to introduction of new products for antibody screening, compatibility testing, and others. For instance, in June 2018 Roche launched COVID19 test that helps detect antibodies against Covid-19 within 2 weeks. This test is based on Roche's proprietary immune monitoring technology which enables rapid detection of Covid-19 infection.
Blood typing is estimated to be fastest growing application owing to its wide applications including paternity testing and infectious disease management & control among other uses such as research purposes or academic studies related to blood groups or transfusion medicine (involving rare antigens).
Regional Analysis:
North America dominated the global automatic blood group diagnostic instrument market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing incidence of infectious diseases. Moreover, rising prevalence of autoimmunity disorders is also expected to drive demand for these tests in this region. For instance, according to data published by National Institute Of Health (NIH), autoimmune diseases are among the top 10 causes for hospital admissions in U.S., affecting more than 6 million people every year and resulting into huge economic burden as well as loss of productivity.
Growth Factors:
- Increasing demand for blood transfusion and blood products
- Rising prevalence of chronic diseases
- Technological advancements in automatic blood group diagnostic instrument market
- Growing number of hospitals and clinics
- Increasing awareness about the benefits of early diagnosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Automatic Blood Group Diagnostic Instrument Market Research Report
By Type
Nucleic Acid Amplification Techniques, Microbiological Technique, Immunohematology Techniques
By Application
Blood Typing, Antibody Screening, Others
By Companies
Hamilton Bonaduz AG, Diagnostic Grifols,S.A., DIAGAST, Aikang, Beckman Coulter K.K., G.S.G. ROBOTIX S.R.L, Hybiome, Ortho-Clinical Diagnostics, Zhongshan Bio-tech, Shandong Xinhua Medical Instrument, WEGO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Automatic Blood Group Diagnostic Instrument Market Report Segments:
The global Automatic Blood Group Diagnostic Instrument market is segmented on the basis of:
Types
Nucleic Acid Amplification Techniques, Microbiological Technique, Immunohematology Techniques
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Typing, Antibody Screening, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hamilton Bonaduz AG
- Diagnostic Grifols,S.A.
- DIAGAST
- Aikang
- Beckman Coulter K.K.
- G.S.G. ROBOTIX S.R.L
- Hybiome
- Ortho-Clinical Diagnostics
- Zhongshan Bio-tech
- Shandong Xinhua Medical Instrument
- WEGO
Highlights of The Automatic Blood Group Diagnostic Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nucleic Acid Amplification Techniques
- Microbiological Technique
- Immunohematology Techniques
- By Application:
- Blood Typing
- Antibody Screening
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Automatic Blood Group Diagnostic Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Automatic Blood Group Diagnostic Instrument (ABGD) is a laboratory instrument that uses automated blood grouping technology to identify the blood group of a sample.
Some of the key players operating in the automatic blood group diagnostic instrument market are Hamilton Bonaduz AG, Diagnostic Grifols,S.A., DIAGAST, Aikang, Beckman Coulter K.K., G.S.G. ROBOTIX S.R.L, Hybiome, Ortho-Clinical Diagnostics, Zhongshan Bio-tech, Shandong Xinhua Medical Instrument, WEGO.
The automatic blood group diagnostic instrument market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Automatic Blood Group Diagnostic Instrument Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Automatic Blood Group Diagnostic Instrument Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Automatic Blood Group Diagnostic Instrument Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Automatic Blood Group Diagnostic Instrument Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Automatic Blood Group Diagnostic Instrument Market Size & Forecast, 2020-2028
4.5.1 Automatic Blood Group Diagnostic Instrument Market Size and Y-o-Y Growth
4.5.2 Automatic Blood Group Diagnostic Instrument Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nucleic Acid Amplification Techniques
5.2.2 Microbiological Technique
5.2.3 Immunohematology Techniques
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Blood Typing
6.2.2 Antibody Screening
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Automatic Blood Group Diagnostic Instrument Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Automatic Blood Group Diagnostic Instrument Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nucleic Acid Amplification Techniques
9.6.2 Microbiological Technique
9.6.3 Immunohematology Techniques
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Blood Typing
9.10.2 Antibody Screening
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nucleic Acid Amplification Techniques
10.6.2 Microbiological Technique
10.6.3 Immunohematology Techniques
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Blood Typing
10.10.2 Antibody Screening
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nucleic Acid Amplification Techniques
11.6.2 Microbiological Technique
11.6.3 Immunohematology Techniques
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Blood Typing
11.10.2 Antibody Screening
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nucleic Acid Amplification Techniques
12.6.2 Microbiological Technique
12.6.3 Immunohematology Techniques
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Blood Typing
12.10.2 Antibody Screening
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nucleic Acid Amplification Techniques
13.6.2 Microbiological Technique
13.6.3 Immunohematology Techniques
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Blood Typing
13.10.2 Antibody Screening
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Automatic Blood Group Diagnostic Instrument Market: Competitive Dashboard
14.2 Global Automatic Blood Group Diagnostic Instrument Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hamilton Bonaduz AG
14.3.2 Diagnostic Grifols,S.A.
14.3.3 DIAGAST
14.3.4 Aikang
14.3.5 Beckman Coulter K.K.
14.3.6 G.S.G. ROBOTIX S.R.L
14.3.7 Hybiome
14.3.8 Ortho-Clinical Diagnostics
14.3.9 Zhongshan Bio-tech
14.3.10 Shandong Xinhua Medical Instrument
14.3.11 WEGO
